An EU task force to assess the burden of rare diseases

Nat Med. 2023 Mar;29(3):516-517. doi: 10.1038/s41591-023-02207-9.

Pavel Kolkhir^{1

2}, Diana Alecsandra Grad³, Periklis Charalampous⁴, Claudia Cruz Oliveira⁴, Enkeleint A Mechili^{5

6}, Brigid Unim⁷, David A Pearce^{8

9

10}, Marcus Maurer^{11

12}, Brecht Devleesschauwer^{13

14}, Juanita Haagsma⁴

¹ Institute of Allergology, Charité-Universitätsmedizin Berlin, Berlin, Germany. pavel.kolkhir@charite.de.
² Allergology and Immunology, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Berlin, Germany. pavel.kolkhir@charite.de.
³ Department of Public Health, Babeş-Bolyai University, Cluj-Napoca, Romania.
⁴ Department of Public Health, Erasmus MC University Medical Center, Rotterdam, the Netherlands.
⁵ Department of Healthcare, Faculty of Health, University of Vlora, Vlora, Albania.
⁶ School of Medicine, University of Crete, Heraklion, Greece.
⁷ Department of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Istituto Superiore di Sanità, Rome, Italy.
⁸ Pediatrics & Rare Diseases Group, Sanford Research, Sioux Falls, SD, USA.
⁹ Sanford Health, Sioux Falls, SD, USA.
¹⁰ Sanford School of Medicine, University of South Dakota, Sioux Falls, SD, USA.
¹¹ Institute of Allergology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
¹² Allergology and Immunology, Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Berlin, Germany.
¹³ Department of Epidemiology and Public Health, Sciensano, Brussels, Belgium.
¹⁴ Department of Translational Physiology, Infectiology and Public Health, Ghent University, Merelbeke, Belgium.

No abstract available

Publication types